What is the optimal fasting insulin range in healthy adults, and at what fasting insulin level or HOMA‑IR score is insulin resistance considered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Optimal Fasting Insulin Range and Insulin Resistance Thresholds

For healthy adults, optimal fasting insulin levels range from approximately 2.5–13 µIU/mL, and insulin resistance is generally considered present when fasting insulin exceeds 13–16 µIU/mL or when HOMA-IR is ≥2.5–3.8, depending on population-specific characteristics.

Optimal Fasting Insulin Range in Healthy Adults

The most robust recent evidence establishes population-specific reference intervals for fasting insulin:

  • General healthy adult range: 2.5–13 µIU/mL 1, 2
    • The 2026 Nepalese study found 2.63–14.56 µIU/mL (median 7.69) in healthy adults 1
    • The 2024 Brazilian study reported 2.52–13.14 µIU/mL for the overall population 2
    • The 2014 Iranian study established 2.11–12.49 µIU/mL 3

Sex differences exist but are clinically minor: Women tend to have slightly higher upper limits (13.30 µIU/mL) compared to men (11.89 µIU/mL), but these differences don't justify separate reference ranges in clinical practice 2.

Age matters: Fasting insulin shows a decreasing trend with advancing age in both sexes 3. Younger adults (20-30 years) typically have higher insulin levels than older adults (46-60 years), reflecting age-related changes in insulin sensitivity.

Insulin Resistance Diagnostic Thresholds

Fasting Insulin Cutoffs

Insulin resistance is diagnosed when fasting insulin exceeds:

  • Men: ≥8 µIU/mL 4
  • Women: ≥10 µIU/mL 4

These thresholds from the 2022 Brazilian study represent mean + 2 SD from metabolically normal individuals and correlate with the presence of metabolic syndrome features 4.

The more conservative approach uses ≥16.7 µIU/mL as the cutoff (90th percentile from subjects without insulin resistance criteria) 5.

HOMA-IR Thresholds

HOMA-IR values indicating insulin resistance:

  • Primary threshold: HOMA-IR ≥2.5–2.86 1, 2

    • The 2026 Nepalese study established 0.39–2.86 as the reference range 1
    • The 2024 Brazilian study confirmed 0.39–2.86 2

  • Alternative threshold: HOMA-IR ≥3.8 5

    • Based on the 90th percentile in Spanish population
    • Associated with 31.8% prevalence of insulin resistance 5

  • Pediatric populations: HOMA-IR ≥4.2 6

    • Optimal cutoff in pubertal children with obesity
    • Higher thresholds needed due to physiological insulin resistance during puberty

QUICKI (Quantitative Insulin Sensitivity Check Index)

Normal insulin sensitivity: QUICKI 0.32–0.42 1, 3

Values below 0.32 indicate insulin resistance. QUICKI is calculated as: 1/[log(fasting insulin µIU/mL) + log(fasting glucose mg/dL)]

Clinical Algorithm for Insulin Resistance Assessment

Step 1: Measure fasting insulin and glucose

  • Ensure true fasting state (8-12 hours)
  • Use standardized assays (chemiluminescence or electrochemiluminescence preferred)

Step 2: Calculate HOMA-IR

  • HOMA-IR = [fasting insulin (µIU/mL) × fasting glucose (mg/dL)] / 405
  • Or use HOMA2-IR calculator for more accuracy

Step 3: Interpret results

  • No insulin resistance: Fasting insulin <8 µIU/mL (men) or <10 µIU/mL (women) AND HOMA-IR <2.5
  • Possible insulin resistance: Fasting insulin 8-16 µIU/mL AND/OR HOMA-IR 2.5-3.8
  • Definite insulin resistance: Fasting insulin >16 µIU/mL AND/OR HOMA-IR >3.8

Step 4: Consider metabolic context

  • Assess for metabolic syndrome components (waist circumference, blood pressure, triglycerides, HDL-cholesterol) 7
  • Even one or two metabolic syndrome criteria combined with hyperinsulinemia suggests Level 1 metabolic syndrome requiring intervention 4

Important Clinical Caveats

Population-specific variations are substantial: Reference ranges established in Western populations may not apply to South Asian, Middle Eastern, or other ethnic groups 1, 8. The 2026 Iraqi study demonstrated significant population-specific differences requiring local reference ranges 8.

BMI significantly affects interpretation: Insulin levels and HOMA-IR increase progressively with BMI 8. In individuals with obesity, higher cutoffs may be appropriate, though this increases risk of missing early insulin resistance.

Avoid relying on triglyceride-based indices alone: While the triglyceride-glucose (TyG) index is promoted as an insulin-free alternative, recent 2026 evidence shows it has inadequate diagnostic accuracy compared to HOMA-IR (AUC 0.572 vs 0.978) 9. Composite indices incorporating BMI and HbA1c perform better but still don't match insulin-based assessments.

Clinical context trumps isolated values: The presence of hepatic steatosis, hypertension, or dyslipidemia alongside borderline insulin values should prompt aggressive intervention regardless of whether formal thresholds are met 4.

Timing of intervention: Don't wait for three or more metabolic syndrome criteria. Evidence supports starting intervention when patients have Level 1 metabolic syndrome (one or two criteria plus hyperinsulinemia) to prevent progression to type 2 diabetes and cardiovascular disease 4.

References

Related Questions

What is the normal value of the Homeostatic Model Assessment (HOMA) index (HOMA‑IR)?
What fasting insulin concentration ranges indicate normal, insulin resistance, hyperinsulinemia, or type 1 diabetes for diagnosing diabetes?
How should a fasting insulin test be performed, what are the normal reference ranges, and how should abnormal results be interpreted and managed?
Is a fasting insulin level below 11.5 µU/mL considered normal, and what treatment or lifestyle recommendations are appropriate?
What is the significance of a fasting insulin level of 31.3 µU/mL and what evaluation and management steps are recommended?
What is the porta hepatis?
What does a urinalysis showing 11–30 white blood cells per high-power field and a urine culture with 25,000–50,000 colony‑forming units per milliliter of mixed urogenital flora indicate?
When and how should Glypressin (synthetic arginine vasopressin) be used, including dosing, for an adult with cirrhosis experiencing acute variceal hemorrhage or for postpartum hemorrhage?
A patient with relapsing‑remitting multiple sclerosis for 4 years on dimethyl fumarate has new non‑enhancing spinal cord lesions on routine MRI but is asymptomatic; what is the appropriate next step in management?
What is the most likely diagnosis and recommended diagnostic and treatment plan for a patient presenting with high‑arched feet (pes cavus), kyphoscoliosis, elevated lactate, and bilateral limb spasticity?
How should serum C-reactive protein (CRP) be used in evaluating suspected intestinal ischemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.